PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
0.870
-0.024 (-2.70%)
At close: Dec 5, 2025, 4:00 PM EST
0.850
-0.020 (-2.30%)
After-hours: Dec 5, 2025, 4:56 PM EST
PDS Biotechnology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -34.88 | -37.61 | -42.94 | -40.85 | -16.92 | -14.85 | |
| Depreciation & Amortization | 0.06 | 0.06 | 0.06 | 0.05 | 0.01 | 0.02 | |
| Other Amortization | 1.38 | 1.16 | 0.65 | 0.18 | - | - | |
| Stock-Based Compensation | 4.59 | 6.85 | 7.61 | 5.2 | 4.07 | 0.43 | |
| Other Operating Activities | 0.96 | 0.27 | 1.18 | 5.24 | 0.28 | 0.18 | |
| Change in Accounts Payable | 3.88 | -5.3 | 5.76 | -0.09 | -0.11 | 0.22 | |
| Change in Other Net Operating Assets | -8.27 | -0.45 | -5.96 | 4.57 | 0.18 | 0.85 | |
| Operating Cash Flow | -32.28 | -35.03 | -33.64 | -25.71 | -12.49 | -13.15 | |
| Capital Expenditures | - | -0.03 | - | - | - | - | |
| Investing Cash Flow | - | -0.03 | - | - | - | - | |
| Long-Term Debt Issued | - | - | - | 25 | - | - | |
| Long-Term Debt Repaid | - | -3.18 | -0.06 | - | - | - | |
| Net Debt Issued (Repaid) | -7.76 | -3.18 | -0.06 | 25 | - | - | |
| Issuance of Common Stock | 13.33 | 23.37 | 16.44 | 10.01 | 48.89 | 29.83 | |
| Repurchase of Common Stock | - | - | - | -0.27 | - | - | |
| Other Financing Activities | 3.16 | - | - | -0.45 | - | - | |
| Financing Cash Flow | 8.73 | 20.19 | 16.38 | 34.29 | 48.89 | 29.83 | |
| Net Cash Flow | -23.55 | -14.87 | -17.26 | 8.58 | 36.4 | 16.68 | |
| Free Cash Flow | -32.28 | -35.06 | -33.64 | -25.71 | -12.49 | -13.15 | |
| Free Cash Flow Per Share | -0.75 | -0.96 | -1.09 | -0.90 | -0.49 | -0.79 | |
| Cash Interest Paid | 3.12 | 3.56 | 3.54 | 0.85 | - | - | |
| Levered Free Cash Flow | -15.31 | -23.34 | -21.17 | -16.47 | -9.04 | -7.68 | |
| Unlevered Free Cash Flow | -13.36 | -21.57 | -19.19 | -15.83 | -9.04 | -7.68 | |
| Change in Working Capital | -4.39 | -5.75 | -0.2 | 4.47 | 0.08 | 1.07 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.